Success Metrics

Clinical Success Rate
50.0%

Based on 3 completed trials

Completion Rate
50%(3/6)
Active Trials
2(20%)
Results Posted
67%(2 trials)
Terminated
3(30%)

Phase Distribution

Ph phase_2
3
30%
Ph phase_4
4
40%
Ph not_applicable
2
20%

Phase Distribution

0

Early Stage

3

Mid Stage

4

Late Stage

Phase Distribution9 total trials
Phase 2Efficacy & side effects
3(33.3%)
Phase 4Post-market surveillance
4(44.4%)
N/ANon-phased studies
2(22.2%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

50.0%

3 of 6 finished

Non-Completion Rate

50.0%

3 ended early

Currently Active

2

trials recruiting

Total Trials

10

all time

Status Distribution
Active(2)
Completed(3)
Terminated(3)
Other(2)

Detailed Status

Completed3
Terminated3
Recruiting2
unknown2

Development Timeline

Analytics

Development Status

Total Trials
10
Active
2
Success Rate
50.0%
Most Advanced
Phase 4

Trials by Phase

Phase 23 (33.3%)
Phase 44 (44.4%)
N/A2 (22.2%)

Trials by Status

completed330%
terminated330%
recruiting220%
unknown220%

Recent Activity

2 active trials
Showing 5 of 10
recruitingphase_4

Dosing of LT4 in Older Individuals

NCT06073665
terminatedphase_4

Use of Tirosint®-SOL or Tablet Formulations of Levothyroxine in Pediatric Patients With Congenital Hypothyroidism (CH)

NCT05228184
recruitingnot_applicable

A Randomized Controlled Trial of Thyroid Hormone Supplementation in Hemodialysis Patients

NCT03977207
completedphase_2

Study of XP-8121 For the Treatment of Adult Subjects With Hypothyroidism

NCT05823012
completed

Quality of Life After Interventional Thyroid Treatment

NCT03880578
View all 10 trials

Clinical Trials (10)

Showing 10 of 10 trials
NCT06073665Phase 4

Dosing of LT4 in Older Individuals

Recruiting
NCT05228184Phase 4

Use of Tirosint®-SOL or Tablet Formulations of Levothyroxine in Pediatric Patients With Congenital Hypothyroidism (CH)

Terminated
NCT03977207Not Applicable

A Randomized Controlled Trial of Thyroid Hormone Supplementation in Hemodialysis Patients

Recruiting
NCT05823012Phase 2

Study of XP-8121 For the Treatment of Adult Subjects With Hypothyroidism

Completed
NCT03880578

Quality of Life After Interventional Thyroid Treatment

Completed
NCT04878614Phase 4

Comparison of Levothyroxine Formulation in Hypothyroid Patients With Enteral Feeding

Terminated
NCT03191188Not Applicable

A Pilot Feasibility Trial of Thyroid Hormone Replacement in Dialysis Patients

Unknown
NCT04132622Phase 4

Low Dose Euthyrox in Treatments of Paraquat Intoxication.

Unknown
NCT03281083Phase 2

Levothyroxine for Non-Alcoholic Fatty Liver Disease (NAFLD)

Terminated
NCT00921050Phase 2

Subclinical Hypothyroidism and Mind in the Elderly

Completed

All 10 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
10